Skip to main content

ribavirin

Generic: RIBAVIRIN·Brand: COPEGUS, REBETOL, RIBASPHERE, RIBAVIRIN, VIRAZOLE

ribavirin: 4 clinical trials tracked.

ribavirin evidence translation

What we can confirm

4 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about ribavirin, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence2 indications · 0 study sponsors

Study sponsors

No additional listed-company sponsor is linked.

Clinical Trial Registry Records (4)

Treatment Protocol for Adults With Hemorrhagic Fever With Renal Syndrome (HFRS) With Intravenous (IV) Ribavirin

NCT04283513Registry updated 2026-07-07·Phase 2
Suspended

Primary endpoint: Reduction in Mortality with IV Ribavirin at 10days

Interventionalopen50 targetStarted 2022-10Completion 2027-071 site · GermanyU.S. Army Medical Research and Development Command

Impact of Interferon Free Regimens in Patients With Chronic HCV and Successfully Treated HCC

NCT02771405Registry updated 2026-04-13·Phase 3
Completed

Primary endpoint: Percentage of Participants With Sustained Virologic Response 12 Weeks After Treatment

Interventionalopen150 enrolledStarted 2016-03Completion 2018-011 site · EgyptNational Hepatology & Tropical Medicine Research Institute

Pilot Study to Assess Efficacy and Safety of a Quadruple Therapy With Asunaprevir, Daclatasvir, Ribavirin and Pegylated Interferon Alpha-2a in HCV Genotype 4-infected Patients Non-responders to Pegylated Interferon-Ribavirin Regimen

NCT02107365Registry updated 2026-04-13·Phase 2
Completed

Primary endpoint: SVR12 Rate

Interventionalopen60 enrolledStarted 2013-11Completion 2015-0425 sites · FranceANRS, Emerging Infectious Diseases

Pilot Study on the Efficacy of Pegylated Interferon-Ribavirin-Boceprevir Triple Therapy in Patients Infected With Genotype 1 HCV With Cirrhosis and Awaiting Liver Transplantation (ANRS HC 29 BOCEPRETRANSPLANT)

NCT01463956Registry updated 2026-04-07·Phase 2
Completed

Primary endpoint: Sustained Virologic Response (SVR) Rate

Interventionalopen58 enrolledStarted 2012-01Completion 2015-0119 sites · FranceFrench National Agency for Research on AIDS and Viral Hepatitis